IL2 and neoplasm: Cytokines enhancing NK-cell proliferation and function such as IL-2 and IL-15 can be used to potentiate NK cell-mediated ADCC against antibody-coated tumor cells (31), offering the potential for multiple combinatorial immunotherapy strategies against cancer.